Internal Server Error

MetriTrack - About the company

MetriTrack is a seed company based in Illinois City (United States), founded in 2014. It operates as an Optimal breast ultrasound technology for earlier, more accurate cancer detection. MetriTrack has raised $2.18M in funding. The company has 85 active competitors, including 37 funded and 10 that have exited. Its top competitors include companies like ScreenPoint, PreludeDx and Syantra Health.

Company Details

Optimal breast ultrasound technology for earlier, more accurate cancer detection. This medical device technology company is focused on advancing breast cancer care through automated breast ultrasound solutions. Their innovations aim to find more breast cancers faster and at a lower cost. They address the critical need for improved detection in women with dense breasts, offering a solution to overcome the limitations of traditional handheld ultrasound. Their FDA-cleared product utilizes proprietary dynamic mapping technology with anatomical referencing for precise breast volume mapping. This supports standardized, reproducible ultrasound exams, improving the quality of care throughout the breast cancer continuum, from detection to treatment. The company's mission is to save lives through earlier and more accurate detection.
Key Metrics
Founded Year
2014
Location
Illinois City, United States
Stage
Seed
Total Funding
$2.18M in 5 rounds
Investors
Ranked
Employee Count
9 as on Apr 30, 2026
Similar Companies
Sign up to download MetriTrack's company profile

MetriTrack's funding and investors

MetriTrack has raised a total funding of $2.18M over 5 rounds. Its first funding round was on Feb 04, 2015. Its latest funding round was a Grant (prize money) round on Mar 01, 2019 for $*****. 1 investor participated in its latest round. MetriTrack has 1 institutional investor.

Here is the list of recent funding rounds of MetriTrack:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Mar 01, 2019
3867587
Grant (prize money)
7622972
5400125
1869185
3764166
Feb 27, 2019
3572270
Seed
2074369
1906558
4231197
1778133
Oct 19, 2018
2897193
Seed
8706330
8002856
6663262
6680882
lockAccess funding benchmarks and valuations. Sign up today!

MetriTrack's founders and board of directors

Founder? Claim Profile

MetriTrack's employee count trend

MetriTrack has 9 employees as of Apr 26. Here is MetriTrack's employee count trend over the years:
Employee count trend for MetriTrack
lockUncover MetriTrack's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

MetriTrack's Competitors and alternates

Top competitors of MetriTrack include ScreenPoint, PreludeDx and Syantra Health. Here is the list of Top 10 competitors of MetriTrack, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for ScreenPoint
ScreenPoint
2014, Nijmegen (Netherlands), Series C
Provider of AI-based medical image analysis systems
$47M
63/100
2nd
Logo for PreludeDx
PreludeDx
2009, Laguna Hills (United States), Series B
Provider of risk assessment test for early stage breast cancer
$51.7M
57/100
3rd
Logo for Syantra Health
Syantra Health
2013, Calgary (Canada), Series A
Developer of a blood test device to detect breast cancer
$10.4M
54/100
4th
Logo for Curasight
Curasight
2013, Copenhagen (Denmark), Series A
Developer of PET ligands for breast cancer indications
$11.5M
53/100
5th
Logo for Isotropic Imaging
Isotropic Imaging
2016, Las Vegas (United States), Public
Innovating breast cancer imaging with dedicated 3D breast CT technology
-
-
48/100
6th
Logo for Devicor Medical
Devicor Medical
1959, Cincinnati (United States), Acquired
Advancing breast care through innovative diagnostic and surgical solutions
$14M
-
48/100
7th
Logo for OncoStem
OncoStem
2011, Bengaluru (India), Series A
Developer of prognostic tests for the detection of cancer
$9M
46/100
8th
Logo for Biotheranostics
Biotheranostics
2008, San Diego (United States), Acquired
Commercial stage molecular diagnostics tests tailored to individual cancer patients.
$32M
44/100
9th
Logo for Mammogen
Mammogen
2020, Aliso Viejo (United States), Seed
Developer of a diagnostic test to detect breast cancer
$2M
-
44/100
10th
Logo for RNA Diagnostics
RNA Diagnostics
2010, Toronto (Canada), Series A
Developer of diagnostic assays for the detection of cancer
$13.8M
41/100
35th
Logo for MetriTrack
MetriTrack
2014, Illinois City (United States), Seed
Optimal breast ultrasound technology for earlier, more accurate cancer detection
$2.18M
 
31/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on MetriTrack's competitors? Click here to see the top ones

MetriTrack's Investments and acquisitions

MetriTrack has made no investments or acquisitions yet.

News related to MetriTrack

lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about MetriTrack

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford